Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | ARG1 | P05089 | 2/20 | 0.33 |
| ▸ | ARG2 | P78540 | 2/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21991115 | 0.93 | SIGMAR1 (0.52) | SIGMAR1ALDH1A1CACNA2D1NPSR1PAOX | |
| SCHEMBL13900575 | 0.84 | ALDH1A1 (0.47) | SIGMAR1ALDH1A1NPSR1FDPSARG1 | |
| SCHEMBL8398213 | 0.83 | ALDH1A1 (0.41) | SIGMAR1ALDH1A1FDPSCHRM2HTR1A | |
| SCHEMBL26453501 | 0.82 | SIGMAR1 (0.43) | SIGMAR1ALDH1A1FDPSCHRM2HTR1A | |
| SCHEMBL678643 | 0.79 | SIGMAR1 (0.38) | SIGMAR1ALDH1A1CACNA2D1NPSR1PAOX | |
| SCHEMBL27320079 | 0.78 | ALDH1A1 (0.62) | SIGMAR1ALDH1A1 | |
| SCHEMBL16819054 | 0.78 | ALDH1A1 (0.41) | ALDH1A1FDPSCHRM2CHRM1OPRM1 | |
| SCHEMBL21991120 | 0.76 | ALDH1A1 (0.39) | SIGMAR1ALDH1A1FDPSOPRM1DRD3 | |
| SCHEMBL28438766 | 0.76 | KCNH2 (0.47) | SIGMAR1FDPSCHRM2SLC6A4OPRM1 | |
| SCHEMBL23451751 | 0.75 | SIGMAR1 (0.36) | SIGMAR1CACNA2D1NPSR1SLC2A1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630570-B2 | Organometallic adduct compound and method of manufacturing integrated circuit device by using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| EP-4130010-B1 | ZINC COMPOUND, RAW MATERIAL FOR THIN FILM FORMATION, THIN FILM, AND METHOD FOR PRODUCING THIN FILM | ADEKA CORP (JP) | 2026-04-29 | — | — | EP | disclosed |
| EP-4067365-B1 | COMPOUND, THIN FILM-FORMING MATERIAL, AND METHOD FOR PRODUCING THIN FILM | ADEKA CORP (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-12577660-B2 | Compound, thin-film forming raw material, thin-film, and method of producing thin-film | ADEKA CORPORATION (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20260055506-A1 | HALOGEN COMPOUND | ADEKA CORPORATION (JP) | 2026-02-26 | — | — | US | disclosed |
| US-20260055507-A1 | THIN-FILM FORMING RAW MATERIAL, THIN-FILM AND METHOD OF PRODUCING THIN-FILM | ADEKA CORPORATION (JP) | 2026-02-26 | — | — | US | disclosed |
| US-12559839-B2 | Indium compound, thin-film forming raw material, thin film, and method of producing same | ADEKA CORPORATION (JP) | 2026-02-24 | — | — | US | disclosed |
| US-12516415-B2 | Reactive material and method of producing thin-film | ADEKA CORPORATION (JP) | 2026-01-06 | — | — | US | disclosed |
| US-12509764-B2 | Thin-film forming raw material used in atomic layer deposition method, and method of producing thin-film | ADEKA CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| EP-4660187-A1 | COMPOUND, RAW MATERIAL FOR THIN FILM FORMATION, THIN FILM, AND METHOD FOR PRODUCING THIN FILM | ADEKA CORPORATION (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-10155784-B2 | Alcohol compound | ADEKA CORPORATION (JP) | 2018-12-18 | — | — | US | disclosed |
| US-20180134739-A1 | ALCOHOL COMPOUND | ADEKA CORPORATION (JP) | 2018-05-17 | — | — | US | disclosed |
| US-9896468-B2 | Metal alkoxide compound, thin-film-forming material, method for producing thin film, and alcohol compound | ADEKA CORPORATION (JP) | 2018-02-20 | — | — | US | disclosed |
| EP-2921472-B1 | METAL ALKOXIDE COMPOUND, THIN FILM-FORMING STARTING MATERIAL, METHOD FOR PRODUCING THIN FILM, AND ALCOHOL COMPOUND | ADEKA CORP (JP) | 2017-01-04 | — | — | EP | disclosed |
| EP-2921472-A1 | METAL ALKOXIDE COMPOUND, THIN FILM-FORMING STARTING MATERIAL, METHOD FOR PRODUCING THIN FILM, AND ALCOHOL COMPOUND | Adeka Corporation (JP) | 2015-09-23 | — | — | EP | disclosed |
| US-20150175642-A1 | METAL ALKOXIDE COMPOUND, THIN-FILM-FORMING MATERIAL, METHOD FOR PRODUCING THIN FILM, AND ALCOHOL COMPOUND | ADEKA CORPORATION (JP) | 2015-06-25 | — | — | US | disclosed |
| EP-1687275-A4 | PYRIDIN-4-YLAMINE COMPOUNDS USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN | MERCK & CO INC (US) | 2009-01-14 | — | — | EP | disclosed |
| US-20070099950-A1 | Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain | AGT SCIENCE LIMITED (GB) | 2007-05-03 | — | — | US | disclosed |
| EP-1687275-A1 | PYRIDIN-4-YLAMINE COMPOUNDS USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN | Merck & Co., Inc. (US) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005051915-A1 | PYRIDIN-4-YLAMINE COMPOUNDS USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN | MERCK & CO., INC. (US) | 2005-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055506-A1 | HALOGEN COMPOUND | SLC9A2, SLC9A1, SLC9B2 | SIGMAR1 1807/4885ALDH1A1 4328/4885CACNA2D1 437/4885 |
| US-20150175642-A1 | METAL ALKOXIDE COMPOUND, THIN-FILM-FORMING MATERIAL, METHOD FOR PRODUCING THIN FILM, AND ALCOHOL COMPOUND | APOB, C9, AOC3 | SIGMAR1 1425/4885ALDH1A1 253/4885CACNA2D1 1069/4885 |
| US-12509764-B2 | Thin-film forming raw material used in atomic layer deposition method, and method of producing thin-film | FTO, NOS1, NOS3 | SIGMAR1 91/4885ALDH1A1 3775/4885CACNA2D1 2301/4885 |
| US-12559839-B2 | Indium compound, thin-film forming raw material, thin film, and method of producing same | RIF1, AUP1, GFRA2 | SIGMAR1 312/4885ALDH1A1 2749/4885CACNA2D1 1475/4885 |
| US-12630570-B2 | Organometallic adduct compound and method of manufacturing integrated circuit device by using the same | C5, AFF2, AFF4 | SIGMAR1 3653/4885ALDH1A1 940/4885CACNA2D1 1311/4885 |
| US-20180134739-A1 | ALCOHOL COMPOUND | ADH1C, ADH1A, APOB | SIGMAR1 582/4885ALDH1A1 66/4885CACNA2D1 1311/4885 |
| US-20070099950-A1 | Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain | PER2, CNR2, OPRD1 | SIGMAR1 582/4885ALDH1A1 2085/4885CACNA2D1 30/4885 |
| US-10155784-B2 | Alcohol compound | ADH1C, ADH1A, C9 | SIGMAR1 1884/4885ALDH1A1 79/4885CACNA2D1 3809/4885 |
| US-20260055507-A1 | THIN-FILM FORMING RAW MATERIAL, THIN-FILM AND METHOD OF PRODUCING THIN-FILM | TMEM109, FTO, YTHDF2 | SIGMAR1 2459/4885ALDH1A1 4140/4885CACNA2D1 211/4885 |
| US-12577660-B2 | Compound, thin-film forming raw material, thin-film, and method of producing thin-film | METTL14, YTHDF2, YTHDF1 | SIGMAR1 1366/4885ALDH1A1 2309/4885CACNA2D1 1463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.